NCT04935463

Mucormycosis in COVID-19

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 728 (actual)
• Sponsor: Montefiore Medical Center · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

The purpose is to allow phsyician reporters to contribute to MUNCO registry. Mucormycosis in COVID-19 is a rapidly escalating medical emergency reported in high numbers in India during the ongoing coronavirus surge. There is very little known about the risk factors, patterns and complications of mucormycosis as it occurs either during the infection or treatment phase of the novel coronavirus (COVID-19). In light of this emerging epidemic within a pandemic, it is of time sensitive importance to obtain a better understanding of the risk factors and outcomes of this fatal complication

Conditions

• Covid19
• Mucormycosis
• Aspergillosis
• Candida Infection

Timeline

• Start date: 2021-05-24
• Primary completion: 2022-03-01
• Completion: 2022-03-01
• First posted: 2021-06-23
• Last updated: 2023-04-18

Locations

1 site across 1 country: United States